Golden Prospect Precious Metals Ltd Notification to Shareholders - 2025 Rights Price

RNS Number : 6700O

Golden Prospect Precious Metals Ltd

04 December 2024

 

4 December 2024

 

 

Golden Prospect Precious Metals Limited

(the "Company")

 

 

Notification to Shareholders in regard to the 2025 Subscription Rights

 

 

Shareholders are reminded that they have the right to subscribe for one new Ordinary Share for every five Ordinary Shares held in the Company on 30 November each year, as outlined in the circular published and sent to shareholders on 4 November 2022.

 

The Company announces the third Subscription Rights Price as being set at 48.00 pence, being the NAV of the Company on 2 December 2024 (given that 30 November 2024 was a non-trading day). The exercise date for the third Subscription Right is expected to be Monday 1 December 2025.

 

The new Ordinary Shares subscribed for will be issued within 14 Business Days of the relevant Subscription Date to those Shareholders in whose name the Ordinary Shares are registered on the Subscription Date.

 

The Board reserves its right to reject subscriptions for Ordinary Shares if the share price is equal to or lesser than the Subscription Price on the exercise date.

 

Enquiries
Manulife | CQS Investment Management       Craig Cleland	[phone]
Cavendish Capital Markets Limited Tunga Chigovanyika (Corporate Finance) Daniel Balabanoff / Pauline Tribe (Sales)	[phone] [phone]
Apex Administration (Guernsey) Limited James Taylor	[phone]
Tavistock Jos Simson / Gareth Tredway / Ruairi Millar	[phone]

 

 

About Golden Prospect Precious Metals

Golden Prospect Precious Metals Limited is a closed-ended investment company incorporated with limited liability in Guernsey on 16 October 2006, which was established to provide a listed entity for investors to gain exposure to the Company's investment strategy within the gold and precious metals sector.

For the latest factsheet and other information, click here.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

ARIUPGRGPUPCGMW